Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 8,797-8,808 of 10,661

Drug study icon

CompletedNCT00216294

Safety Study of the Drug RG1068 in people with OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugFrom 18 Years to 40 Years

Countries: United States
Sponsor: Indiana University
Condition: OCD

Other study type icon

CompletedNCT01805518

Safety Study of the Effect of Scelectium Tortuosum (as Zembrin®)in Aged Normals

This summary needs review. Please check the official study record and contact the research team for details.

Broader result

SuicidalityOtherFrom 45 Years to 65 Years

Countries: United States
Sponsor: Woodbury, Michel, M.D.
Condition: Suicidality

Drug study icon

CompletedNCT00490542

Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Tufts Medical Center
Condition: Depression, Bipolarity

Behavioral study icon

UnknownNCT05834660

SAFETY-A for Promoting Equity in Suicide prevention Outcomes in Schools

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityBehavioralOver 11 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: Suicidality

Behavioral study icon

Enrolling By InvitationNCT06460220

SAFETY-Parent: Online Learning Module to Support Parents of Suicidal Youth

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

SuicidalityBehavioralFrom 10 Years to 18 Years

Countries: United States
Sponsor: Jennifer Hughes
Condition: Suicidality

Drug study icon

CompletedNCT04822883

Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Recognify Life Sciences
Condition: Schizophrenia

Drug study icon

CompletedNCT00247572

Safety study of Intravenous NRP104 in Addiction

This study is completed in the United States. It is testing Intravenous NRP104 for Addiction.

In United States

AddictionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: New River Pharmaceuticals
Condition: Addiction

Drug study icon

CompletedNCT00640185

Safety study of ABT-089 in ADHD

This study is completed in the United States. It is testing ABT-089 for ADHD.

In United States

ADHDDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: AbbVie (prior sponsor, Abbott)
Condition: ADHD

Drug study icon

CompletedNCT04035200

Safety study of V117957 in Addiction

This study is completed in the United States. It is testing V117957 for Addiction.

In United States

AddictionDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: Imbrium Therapeutics
Condition: Addiction

Drug study icon

CompletedNCT01879722

Safety study of Multiple Rising Doses of TAK- 063 in schizophrenia

This study is completed in the United States. It is testing Multiple Rising Doses of TAK- 063 for schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Takeda
Condition: Schizophrenia

Drug study icon

CompletedNCT05447286

Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study

This study is completed in the United States. It focuses on Addiction.

In United States

AddictionDrugFrom 21 Years to 58 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Drug study icon

CompletedNCT03327402

Safety study of SHP465 in ADHD

This study is completed in the United States. It is testing SHP465 for ADHD.

In United States

ADHDDrugFrom 4 Years to 5 Years

Countries: United States
Sponsor: Shire
Condition: ADHD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.